Abstract
Clinical studies have demonstrated that cilostazol (CZ), an antiplatelet agent with type 3 phosphodiesterase inhibition, reduces the risk of secondary stroke. To analyze CZ's vascular action, especially in relation to endothelial and perivascular nerve functions, we examined CZ's effects on the responses to endothelial and nerve stimulation in dog cerebral arteries, and on the response to nerve stimulation in dog mesenteric arteries. Low concentrations of CZ (10−8 and 10−7 mol/L) failed to relax the cerebral arteries, but a higher concentration (10−6 mol/L) relaxed them in an endothelium-independent manner. Substance P-induced relaxation was endothelium-dependent in the cerebral arteries, whereas transmural electrical stimulation (TES) and nicotine-induced relaxation were endothelium-independent. This relaxation was abolished by NGnitro- L-arginine, an NO synthase (NOS) inhibitor. A lower concentration (10−7 mol/L) of CZ enhanced the relaxation caused by nerve-derived NO but did not affect the relaxation caused by endothelium-derived NO in the cerebral arteries; moreover, it did not affect the contractions caused by nerve-derived noradrenaline in the mesenteric arteries under treatment with the NOS inhibitor. It is concluded that CZ may selectively enhance nitrergic nerve function, possibly via the activation of neuronal NOS, in dog cerebral arteries, since it does not affect the function of the noradrenergic nerve or that of endothelial NOS. Therefore, this novel vasodilatory effect of CZ may explain the reduction in the risk of secondary stroke in addition to the antiplatelet action and the direct vasodilatory action on smooth muscle.
Similar content being viewed by others
Article PDF
References
Dogne JM, de Leval X, Benoit P, Delarge J, Masereel B, David JL : Recent advances in antiplatelet agents. Curr Med Chem 2002; 9: 577–589.
Kubo M, Kiyohara Y, Kato I, et al: Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003; 34: 2349–2354.
Sytkowski PA, D'Agostino RB, Belanger A, Kannel WB : Sex and time trends in cardiovascular disase incidence and mortality: the Framingham Heart Study, 1950-1989. Am J Epidemiol 1996; 143: 338–350.
Gotoh F, Tohgi H, Hirai S, et al: Cilostazol Stroke Prevention Study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis 2000; 9: 147–157.
Liao F : Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer? Circulation 2007; 115: 1615–1621.
Förstermann U, Schmidt HHHW, Pollock JS, et al: Isoforms of nitric oxide synthase: characterization and purification from different cell types. Biochem Pharmacol 1991; 42: 1849–1857.
Moncada S, Higgs A, Furchgott RF : XIV. International union of pharmacology nomenclature in nitric oxide research. Pharmacol Rev 1997; 49: 137–142.
Toda N, Okamura T : The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev 2003; 55: 271–324.
Toda N, Hatano Y, Hayashi S : Modifications by stretches of the mechanical response of isolated cerebral and extracerebral arteries to vasoactive agents. Pflügers Arch 1978; 374: 73–77.
Cocks TM, Angus JA : Comparison of relaxation responses of vascular and non-vascular smooth muscle to endothelium- derived relaxing factor (EDRF), acidified sodium nitrite (NO) and sodium nitroprusside. Naunyn Schmiedebergs Arch Pharmacol 1990; 341: 364–372.
Toda N, Okamura T : Neurogenic nitric oxide (NO) in the regulation of cerebroarterial tone. J Chem Neuroanatomy 1996; 10: 259–265.
Toda N, Okamura T : Different susceptibility of vasodilator nerve, endothelium and smooth muscle functions to Ca++ antagonists in cerebral arteries. J Pharmacol Exp Ther 1992; 261: 234–239.
Toda N, Uchiyama M, Okamura T : Prejunctional modulation of nitroxidergic nerve function in canine cerebral arteries. Brain Res 1995, 700: 213–218.
Schrör K : The pharmacology of cilostazol. Diabetes Obes Metab 2002; 4 ( Suppl 2): S14–S19.
Ikeda Y : Antiplatelet therapy using cilostazol, a specific PDE3 inhibitor. Thromb Haemost 1999; 82: 435–438.
Ayajiki K, Okamura T, Fujioka H, Nakayama K, Tsuji K, Toda N : Functional studies on blockade by neosurugatoxin of nicotinic receptors in nitroxidergic and sensory nerve terminals and intramural ganglionic cells. Jpn J Pharmacol 1998; 78: 217–223.
Toda N, Ayajiki K, Yoshida K, Kimura H, Okamura T : Impairment by damage of the pterygopalatine ganglion of nitroxidergic vasodilator nerve function in canine cerebral and retinal arteries. Circ Res 1993; 72: 206–213.
Sui H, Wang W, Wang PH, Liu LS : Protective effect of antioxidant ebselen (PZ51) on the cerebral cortex of strokeprone spontaneously hypertensive rats. Hypertens Res 2005; 28: 249–254.
Choi JM, Shin HK, Kim KY, Lee JH, Hong KW : Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J Pharmacol Exp Ther 2002; 300: 787–793.
Onoue H, Nakamura N, Toda N : Endothelium-dependent and -independent responses to vasodilators of isolated dog cerebral arteries. Stroke 1988; 19: 1388–1394.
Toda N, Okamura T : Role of nitric oxide in neurally induced cerebroarterial relaxation. J Pharmacol Exp Ther 1991; 258: 1027–1032.
Nakamura T, Houchi H, Minami A, et al: Endotheliumdependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta. Life Sci 2001; 69: 1709–1715.
Hashimoto A, Miyakoda G, Hirose Y, Mori T : Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/ Akt-dependent mechanism. Atherosclerosis 2006; 189: 350–357.
Béa ML, Ghaleh B, Giudicelli JF, Berdeaux A : Lack of importance of NO in beta-adrenoceptor-mediated relaxation of large epicardial canine coronary arteries. Br J Pharmacol 1994; 111: 981–982.
Cameron NE, Cotter MA : The effects of 5-hydroxytryptamine 5-HT2 receptor antagonists on nerve conduction velocity and endoneurial perfusion in diabetic rats. Naunyn Schmiedebergs Arch Pharmacol 2003; 367: 607–614.
Yamamoto Y, Yasuda Y, Kimura Y, Komiya Y : Effects of cilostazol, an antiplatelet agent, on axonal regeneration following nerve injury in diabetic rats. Eur J Pharmacol 1998; 352: 171–178.
Toda N, Okamura T, Nakajima M, Miyazaki M : Modification by yohimbine and prazosin of the mechanical response of isolated dog mesenteric, renal and coronary arteries to transmural stimulation and norepinephrine. Eur J Pharmacol 1984; 98: 69–78.
Zhang JX, Okamura T, Toda N : Prejunctional regulation by endogenous and exogenous acetylcholine of adrenergicnerve function in isolated canine mesenteric arteries. Hypertens Res 1997; 20: 119–125.
Ferrer M, Sánchez M, Martín Mdel C, et al: Protein kinase A increases electrical stimulation-induced neuronal nitric oxide release in rat mesenteric artery. Eur J Pharmacol 2004; 487: 167–173.
Toda N, Ayajiki K, Okamura T : Neural mechanism underlying basilar arterial constriction by intracisternal L-NNA in anesthetized dogs. Am J Physiol 1993; 265 ( 1 Pt 2): H103–H107.
Toda N, Ayajiki K, Tanaka T, Okamura T : Preganglionic and postganglionic neurons responsible for cerebral vasodilation mediated by nitric oxide in anesthetized dogs. J Cereb Blood Flow Metab 2000, 20: 700–708.
Birk S, Kuuse C, Petersen KA, Tfelt-Hansen P, Olesen J : The headache effect of cilostazol in human volunteers. Cephalalgia 2006; 26: 1304–1309.
Ayajiki K, Fujioka H, Noda K, Okamura T, Toda N : Modifications by sumatriptan and acetylcholine of nitric oxide- mediated neurogenic dilatation in dog cerebral arteries. Eur J Pharmacol 2001; 420: 67–72.
Boswell-Smith V, Spina D, Page CP : Phosphodiesterase inhibitors. Br J Pharmacol 2006; 147 ( Suppl 1): S252–S257.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ayajiki, K., Ozeki, Y., Wang, C. et al. Cilostazol's Effect on the Response to Perivascular Nerve Stimulation in Isolated Dog Cerebral and Mesenteric Arteries. Hypertens Res 31, 1425–1433 (2008). https://doi.org/10.1291/hypres.31.1425
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.31.1425
Keywords
This article is cited by
-
Recent advances in research on nitrergic nerve-mediated vasodilatation
Pflügers Archiv - European Journal of Physiology (2015)